Charité - Universitätsmedizin Berlin
| Germania | Turchia | Austria | |
| Trattamento complesso del sarcoma di Ewing | da $95,000 | da $30,000 | da $55,000 |
| Terapia radiante per sarcomi | da $15,000 | da $3,250 | da $18,000 |
| Resezione ossea | da $30,000 | da $8,000 | da $25,000 |
| Radioterapia per il cancro colorettale | da $20,000 | da $7,000 | da $12,000 |
| Chirurgia del sarcoma | da $60,000 | da $10,000 | da $35,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Sarcoma di Ewing. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Sarcoma di Ewing e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Sarcoma di Ewing.
Il medico è un oncologo affermato con un focus su trattamenti innovativi per il cancro e ricerca. Come capo del Centro di Oncologia presso Charite, il medico guida un team dedicato ad avanzare nella cura oncologica e migliorare i risultati dei pazienti attraverso terapie all'avanguardia e sperimentazioni cliniche. Con un forte impegno per l'educazione e la ricerca, il medico ha contribuito significativamente al campo dell'oncologia, partecipando a numerosi studi e pubblicazioni di grande impatto.<\/p>
Orthopedic surgeon
Head of the Department of Pediatric oncology
Il medico è un gastroenterologo altamente valutato in Europa, riconosciuto tra i primi 100 medici in Germania per il trattamento delle lesioni gastrointestinali. Il medico contribuisce allo sviluppo delle linee guida tedesche per il trattamento del cancro esofageo e si specializza nei tumori del tratto gastrointestinale.<\/p>
Dal 2000, il medico è Direttore della Clinica di Medicina Interna presso la Clinica Bremen-Ost in Germania. I ruoli precedenti includono posizioni di ricercatore presso l'Istituto di Cancro MD Anderson e l'Università Heinrich Heine. Il medico possiede un Premio Clinico per la Gastroenterologia e un Premio al Merito dal Simposio sui Tumori Gastrointestinali.<\/p>
Germany follows the official Onkopedia guidelines for Ewing sarcoma. The standard protocol involves intensive multimodal therapy. This includes neoadjuvant chemotherapy, local control through surgery or radiation, and adjuvant chemotherapy. Treatment usually lasts around 12 months in specialized German university hospitals.
Bookimed Expert Insight: German university hospitals like Charite Berlin and Essen University Hospital manage massive volumes of over 370,000 patients yearly. This high volume allows centers to participate in trials like EURO EWING 2012. Our data shows that because these are research-heavy institutions, patients often receive the newest VDC/IE backbone protocols before they become global standards.
Patient Consensus: Patients emphasize that treatment is a systemic fight from day one. They note that starting rapidly at a specialist center is vital. Many highlight the emotional importance of the first MRI response after induction cycles. They also suggest discussing fertility preservation before the very first chemotherapy session starts.
German clinics treat recurrent Ewing sarcoma using personalized multi-modal salvage protocols. Comprehensive tumor boards at university centers design these plans. Treatment typically combines risk-stratified chemotherapy, aggressive surgery, and precision radiation. Specialized facilities prioritize clinical trial enrollment to access novel targeted therapies.
Bookimed Expert Insight: University hospitals like Charité and Essen University Hospital manage the highest case volumes. Charité alone serves over 845,000 patients annually and holds German Cancer Society certification. This massive volume allows specialists like Dr. Angelika Eggert to refine salvage protocols for refractory cases. Our data shows these academic centers often integrate research directly into treatment. Patients at Essen or Charité may access innovative techniques under one roof. This integration is vital for complex sarcomas requiring both orthopedic and oncological expertise.
Patient Consensus: Patients note that German teams act quickly once recurrence is detected. They emphasize that while salvage therapy is intense, doctors provide clear guidance on balancing aggressive treatment with preserving physical function.
German clinics strictly prioritize limb-sparing surgery for Ewing's sarcoma. Specialized centers achieve limb salvage in approximately 90% of bone tumor cases. Surgeons utilize neoadjuvant chemotherapy and modular endoprostheses to avoid amputation. Radical procedures remain a last resort only when safe margins are impossible.
Bookimed Expert Insight: Data from leading facilities like Charité - Universitätsmedizin Berlin shows a heavy emphasis on pediatric specialization. Dr. Angelika Eggert and others focus on combining research with treatment. Choosing a university hospital is vital because they integrate innovative oncology trials directly into patient care.
Patient Consensus: Patients note that teams work hard for limb-sparing results when chemotherapy controls the tumor. Many emphasize asking about functional outcomes, as a saved limb requires long rehabilitation and hardware care.
Germany possesses a sophisticated network of particle therapy centers providing proton beam and carbon ion therapy. These facilities often treat Ewing's sarcoma when tumors reside near critical organs. Specialized university hospitals integrate these advanced beams with multispecialty oncology care for pediatric and adult patients.
Bookimed Expert Insight: While proton therapy is a top request, its use depends heavily on tumor location. Essen University Hospital serves 370,000 patients annually and leads in innovative techniques. Accessing these advanced therapies often requires a review by a multidisciplinary tumor board at a large academic center. Hospitals like Charité, with 4,200+ doctors, provide this comprehensive evaluation to see if particle therapy is truly superior for your specific case.
Patient Consensus: Patients note that proton therapy is not always the first recommendation. It is vital to seek a second opinion at a major sarcoma center to confirm if this treatment fits your anatomy.
Ewing's sarcoma treatments in Germany may impact fertility and long-term growth depending on protocol. Chemotherapy and radiation can reduce reproductive cells or affect bone growth plates. Specialists at centers like Charite Berlin or Essen University Hospital emphasize early preservation and monitoring during pediatric care.
Bookimed Expert Insight: Our data shows Germany's university hospitals, like Charite Berlin, integrate pediatric oncology with specialized fertility preservation centers. This is vital because these clinics handle over 800,000 patients yearly and provide cross-departmental care. Patients should request a fertility consultation during the initial diagnostic phase, as protocols move very quickly once the biopsy results arrive.
Patient Consensus: Patients note that doctors focus heavily on starting treatment fast. It is essential to ask about egg or sperm banking immediately to ensure options remain available.
Essen University Hospital and Charité - Universitätsmedizin Berlin specialize in Ewing's sarcoma treatment in Germany. These centers utilize multidisciplinary tumor boards and specialized orthopedic oncology. Accredited institutions provide limb-sparing surgery, precise radiation therapy, and complex chemotherapy protocols for bone and soft-tissue tumors.
Bookimed Expert Insight: While many search for general oncology, Ewing's sarcoma requires specific surgical volume. Data from Charité shows they employ over 4,200 doctors across 100 departments. This allows Dr. Michael Schütz to coordinate directly with pediatric oncologists like Dr. Angelika Eggert. This level of internal collaboration is essential for rare bone cancers.
Patient Consensus: Patients emphasize the need for a dedicated sarcoma board and expert pathology reviews before starting therapy. Those visiting the University Clinic of Leipzig note high satisfaction with the structured consultation process.